| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | myricetin | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | CD-1530 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | 0.039 | 0.2 |
| mRNA | GSK1120212 | CTRPv2 | pan-cancer | AAC | -0.059 | 0.2 |
| mRNA | FSC231 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.3 |
| mRNA | RAF265 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.3 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.058 | 0.3 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.3 |
| mRNA | tacedinaline | CTRPv2 | pan-cancer | AAC | 0.044 | 0.3 |
| mRNA | BMS-345541 | GDSC1000 | pan-cancer | AAC | -0.034 | 0.3 |